Eponyms in Oncology: Lynch Syndrome
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of Lynch syndrome.
Gynecologic Cancers
Fuzuloparib Maintenance Prolongs PFS in Recurrent Ovarian Cancer
Fuzuloparib maintenance significantly delayed the time to disease progression and time to subsequent chemotherapy.
Eponyms in Oncology: HeLa Cells
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of HeLa cells.
Bevacizumab Biosimilar Alymsys Gets FDA Approval
The approval was based on data demonstrating that the biosimilar product and the reference product were highly similar, and that there were no clinically meaningful differences between the agents.
Risk of Breakthrough COVID-19 Varies by Cancer Type
The risk of breakthrough SARS-CoV-2 infections was highest for liver cancer and lowest for thyroid cancer.
Rucaparib Prolongs PFS in BRCA-Mutated, Relapsed Ovarian Cancer
The median duration of response was significantly longer with rucaparib than with standard chemotherapy.
Findings Support Retesting for MMRD at Uterine Cancer Recurrence
Patients who have mismatch repair proficiency in the primary setting may have mismatch repair deficiency at recurrence.
Eponyms in Oncology: Virchow’s Node
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of Virchow’s node.
Olaparib Alone, in Combination Does Not Improve PFS in Platinum-Sensitive Ovarian Cancer
Despite the lack of improvement in the overall cohort, olaparib monotherapy and olaparib-cediranib did exhibit activity in a subset of patients with a germline BRCA mutation.
Cancer Is Associated With Increased Kidney Failure Risk
The risk for kidney failure requiring renal replacement therapy varies by cancer type, with multiple myeloma associated with the highest risk.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...